Low-Dose vs Standard-Dose Indomethacin for Pancreatitis Prevention After ERCP
Part of Digestive system clinical trials.
This study compares a low dose of indomethacin (a pain reliever) with the standard dose to see if it works just as well for preventing pancreatitis (inflammation of the pancreas) after an ERCP procedure. It may reduce side effects while still protecting your pancreas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to have an ERCP procedure (a scope to look at bile ducts).
- You are not allergic to NSAIDs (like ibuprofen or aspirin).
- You have not taken any NSAID in the week before ERCP.
- You do not have recent stomach bleeding, kidney problems, or a bleeding disorder.
- You do not have acute pancreatitis (sudden severe pancreas inflammation) within the last 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether higher doses of a common anti-inflammatory drug (indomethacin) given as a suppository can better prevent pancreatitis after an ERCP procedure in people who are at high risk for this complication.
This study compares indomethacin (an anti-inflammatory medicine) against using a temporary pancreatic stent to prevent pancreatitis after an ERCP procedure. It may help you lower the chance of painful inflammation of the pancreas after ERCP.
This study tests whether a rectal suppository of indomethacin (a type of anti-inflammatory) can help prevent complications during a bile duct procedure called ERCP. It's for people who have already had a prior bile duct cut.
This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.
This study compares two common NSAID medications (indomethacin and diclofenac) given before an ERCP procedure to see if one is better at preventing pancreatitis, a common complication. If you are having an ERCP and meet the health criteria, you may be able to join.
This trial tests whether parecoxib or indomethacin works better at preventing pancreatitis, a common complication after a procedure called ERCP. Participants will receive one of the two medicines before the procedure, and the study will track which one is safer and more effective.
Hear when a new Post-ERCP Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.